FDA tells CAR-T makers to add boxed warnings of secondary cancer – Endpoints News - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
The FDA has told Novartis, Gilead, Bristol Myers Squibb and Johnson & Johnson to add boxed warnings on the labels of six CAR-T therapies noting the risks of secondary cancer. The agency caused a stir in the CAR-T space when it revealed the safety review in No…